Ep Wealth Advisors, LLC Novo Nordisk A S Transaction History

Ep Wealth Advisors, LLC

$11.3 Billion
Q3 2024

A detailed history of Ep Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 75,566 shares of NVO stock, worth $7.69 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

75,566

Previous 65,844 14.77%

Holding current value

$7.69 Million

Previous $9.4 Million 4.27%

% of portfolio

0.08%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $1.16 Million - $1.41 Million	9,722 Added 14.77%	75,566 $9 Million
Q2 2024 Aug 19, 2024	BUY	$122.71 - $146.91 $2.21 Million - $2.64 Million	17,982 Added 37.57%	65,844 $9.4 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $197,582 - $263,005	1,935 Added 4.21%	47,862 $6.15 Million
Q4 2023 Feb 28, 2024	BUY	$87.78 - $105.45 $94,890 - $113,991	1,081 Added 2.41%	45,927 $4.75 Million
Q3 2023 Nov 22, 2023	BUY	$90.94 - $199.54 $3.31 Million - $7.26 Million	36,404 Added 431.22%	44,846 $4.08 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $10.6 Million - $11.7 Million	-67,647 Reduced 88.91%	8,442 $1.37 Million
Q1 2023 Jun 05, 2023	BUY	$132.34 - $159.14 $8.03 Million - $9.65 Million	60,649 Added 392.8%	76,089 $12.1 Million
Q4 2022 Jun 12, 2023	SELL	$102.55 - $135.33 $6.16 Million - $8.13 Million	-60,096 Reduced 78.98%	15,993 $2.16 Million
Q3 2022 Dec 02, 2022	BUY	$95.28 - $116.93 $1.01 Million - $1.24 Million	10,611 Added 219.73%	15,440 $1.54 Million
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $21,060 - $24,849	204 Added 4.41%	4,829 $538,000
Q1 2022 May 20, 2022	SELL	$93.1 - $112.54 $29,047 - $35,112	-312 Reduced 6.32%	4,625 $514,000
Q4 2021 Feb 17, 2022	BUY	$95.88 - $117.08 $69,033 - $84,297	720 Added 17.07%	4,937 $553,000
Q3 2021 Nov 23, 2021	SELL	$84.42 - $106.62 $678,736 - $857,224	-8,040 Reduced 65.6%	4,217 $405,000
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $736,395 - $930,046	8,723 Added 246.83%	12,257 $405,000
Q2 2021 Aug 24, 2021	BUY	$67.66 - $84.76 $9,878 - $12,374	146 Added 4.31%	3,534 $296,000
Q4 2020 Feb 18, 2021	BUY	$63.89 - $73.8 $216,459 - $250,034	3,388 New	3,388 $237,000

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ep Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ep Wealth Advisors, LLC with notifications on news.

Account

Ep Wealth Advisors, LLC Novo Nordisk A S Transaction History